Exciting things to are happening in the labs at Washington University School of Medicine. Here is one of the facilities where our great minds are working!
We were excited to learn that our partners at Sage therapeutics have published trials of a formulation of the neurosteroid allopregnanolone for postpartum depression treatment. Another neuroactive steroid completed Phase 2 trials for Major Depressive Disorder and was recently designated FDA Breakthrough Status. This work seems to validate the studies we and others have done over the years characterizing […]